Terms

Effective September 17, 2026.

Submitting an application does not create an engagement, guarantee acceptance, or constitute investment, legal, tax, financial, securities, real-estate, medical, clinical, pharmaceutical, insurance, or other professional advice.

Any partnership is subject to a separate written agreement covering scope, fees, equity, revenue share, ad spend, buildout expenses, confidentiality, compliance, termination, governing law, and applicable regulation. The advertised $800,000+ setup fee, 24-month term, 80% Tantalum equity and information-product revenue-share participation, and Tantalum-funded advertising spend regardless of amount are subject to that final agreement.

Case-study figures are client-reported, directional, and published with permission. Revenue, contracted revenue, and ARR are not profit figures or guarantees of future results.

Tantalum does not provide professional advice or create a client relationship in a regulated field. Partners and purchasers remain responsible for their own licensing, compliance, diligence, and use of independent professional advisers.

Tantalum Ventures may decline applications that are seeking a get-rich-quick scheme or that do not meet the stated capital, operating-history, and commitment requirements. For privacy or terms questions, email aryan@tantalumventures.com.